EXELIXIS INC (NASDAQ:EXEL) was identified by our screener as a strong growth stock with a favorable technical setup. The company combines solid fundamentals with a promising price pattern, making it worth a closer look for investors seeking growth opportunities.
Strong Growth Fundamentals
EXELIXIS stands out with an 8/10 Growth Rating, supported by:
- Earnings Growth: EPS surged 205.56% over the past year, with a 5-year average annual growth of 12.65%.
- Revenue Growth: Sales increased 24.50% YoY, with a 17.51% average annual growth rate.
- Future Expectations: Analysts project EPS growth of 25.80% annually, outpacing many industry peers.
The company also scores well on profitability (8/10) and financial health (9/10), with no debt and strong margins.
Technical Setup
The stock shows a bullish technical structure:
- Trend Strength: Both short-term and long-term trends are positive.
- Support Levels: Key support zones between $40.36 and $41.12 provide a potential floor for pullbacks.
- Breakout Potential: A resistance zone near $46.26 could signal further upside if breached.
Volume has increased recently, suggesting growing investor interest.
Valuation
Despite strong growth, EXEL appears reasonably valued:
- P/E of 19.85 is below the S&P 500 average (26.98).
- 95% of biotech peers trade at higher P/E ratios.
Our Strong Growth Stocks with Good Technical Setup screener lists more candidates with similar traits.
For deeper analysis, review the full fundamental report and technical report.
Disclaimer
This is not investment advice. Always conduct your own research before making decisions.
